HAVE OUR BACKS
×
Sign Up
Already Registered?
face
lock_outline
THE FACTS
BIO
BIO
VOTES
VOTES
POSITIONS
POSITIONS
RATINGS
RATINGS
SPEECHES
SPEECHES
FUNDING
FUNDING
Please have our backs
No Thank You
Henry Waxman's Public Statements on Issue: Drugs
Track This Politician
Current Issue:
Drugs
Select Issue
All
Abortion
Agriculture and Food
Animals and Wildlife
Arts, Entertainment, and History
Business and Consumers
Campaign Finance
Civil Liberties and Civil Rights
Constitution
Criminal Justice
Death Penalty
Defense
Drugs
Economy and Fiscal
Education
Elections
Employment and Affirmative Action
Energy
Entitlements and the Safety Net
Environment
Executive Branch
Family
Federal, State and Local Relations
Finance and Banking
Food Processing and Sales
Foreign Affairs
Foreign Aid
Gambling and Gaming
Government Budget and Spending
Government Operations
Guns
Health Insurance
Health and Health Care
Higher Education
Housing and Property
Immigration
Indigenous Peoples
Infrastructure
Judicial Branch
K-12 Education
Labor Unions
Legal
Legislative Branch
Marijuana
Marriage
Military Personnel
Minors and Children
Monetary Policy
National Security
Natural Resources
Oil and Gas
Religion
Reproduction
Science
Senior Citizens
Sexual Orientation and Gender Identity
Stem Cell Research
Taxes
Technology and Communication
Trade
Transportation
Unemployed and Low-Income
Veterans
Women
Speech Type
Select Speech Type
All
Debate
Executive Order
Floor Speech
Hearing
Interview
Issue Position
Letter
News Article
Op-Ed
Other
Pledge
Press Conference
Press Release
Social Media
Speech
Statement
Date Range
Start Date
End Date
Apply
Keyword Search
close
Reset Search
attach_money
Who is funding Waxman?
Page 1 of 3
1
2
3
chevron_right
Date
Title
09/15/2014
Designer Anabolic Steroid Control Act of 2014
04/29/2014
Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Examining the Growing Problems of Prescription Drug and Heroin Abuse
04/08/2014
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Examining the Implementation of the Tobacco Control Act
04/07/2014
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Improving Predictability and Transparency in DEA and FDA Regulation
04/01/2014
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Examining Concerns Regarding FDA's Proposed Changes to Generic Drug Labeling
02/27/2014
Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Counterfeit Drugs: Fighting Illegal Supply Chains
11/08/2013
Leahy Leads Coalition of Lawmakers in Welcoming the FDA's Release of Proposed Rules To Protect Consumers Using Generic Drugs
07/16/2013
Hearing of the House Health Subcommittee of the Energy and Commerce Committee - Reforming the Drug Compounding Regulatory Framework
06/17/2013
Rep. Waxman Statement on Supreme Court Decision on Generic Drug Competition
06/14/2013
Hearing of the House Health Subcommittee of the Energy and Commerce Committee - Examining the Federal Government's Response to the Prescription Drug Abuse Crisis
10/09/2012
Letter to Chairman Upton, Chairman Pitts, and Chairman Stearns
03/27/2012
Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Examining the Current State of Cosmetics
03/20/2012
Letter to Jon Leibowitz, Chairman Federal Trade Commission - Pharmacy Merger
03/01/2012
Hearing of the Commerce, Manufacturing, and Trade Subcommittee of the House Energy and Commerce Committee - Prescription Drug Diversion: Combating the Scourge
01/01/2012
Issue Position: Health - Tobacco
01/01/2012
Issue Positions: Affordable Medications
01/01/2012
Issue Position: Health - Drug and Medical Device Safety
01/01/2012
Issue Position: Health - Affordable Medications
01/01/2012
Issue Position: Judiciary
01/01/2012
Issue Position: Federal Drug Policy
12/07/2011
Synthetic Drug Control Act of 2011
10/25/2011
Letter to Chairman Upton
10/13/2011
Letter to The Honorable Patty Murray Chairwoman and The Honorable Jeb Hensarling Chairman Joint Select Committee for Deficit Reduction
06/16/2011
House Democratic Leaders Introduce Legislation to Save More Than $100 Billion in Medicare Drug Costs
06/01/2011
House Appropriations Committee Passes Bill to Weaken Critical FDA Public Health Functions
Page 1 of 3
1
2
3
chevron_right
attach_money
Who is funding Waxman?
clear
Log in
face
lock_outline
face
person
person_outline
email
lock
lock_outline
Enter the same password as above, for verification.
arrow_upward